DAWN — Day One Biopharmaceuticals Share News
0.000.00%
Last trade - 00:00- $2.22bn
- $1.78bn
- $158.18m
U.S. STOCKS ON THE MOVE-Chevron, Coherent, HF Sinclair
Day One Biopharma rises on research, licensing deal with Sprint Bioscience
Brief: Day One Biopharmaceuticals Inc Announces VRK1 License Agreement And Research Collaboration With Sprint Bioscience
Brief: Day One Biopharmaceuticals - Expects Cash, Short-Term Investments To Fund Opex Into 2026
U.S. STOCKS ON THE MOVE-Biogen, Phoenix Motor, Mastercard
U.S. STOCKS ON THE MOVE-Energy sector, Affirm, Stitch Fix
U.S. STOCKS ON THE MOVE-Shutterstock, Salesforce, Plug Power
U.S. STOCKS ON THE MOVE-TransCode Therapeutics, Yext, Netflix
Day One Biopharmaceuticals slides on stock offering
Brief: Day One Announces Pricing Of Public Offering Of Common Stock
Brief: Day One Announces Proposed Public Offering Of Common Stock
U.S. STOCKS ON THE MOVE-Spotify, Akero Therapeutics, Cyxtera Technologies
U.S. STOCKS ON THE MOVE-Tesla, Moderna, Oil tanker firms
Cancer drugmakers rise as industry meet fuels investor interest (updated)
U.S. STOCKS ON THE MOVE-Foghorn Therapeutics, Novavax, Apple
Cancer drugmakers rise as industry meet fuels investor interest
Cancer drug developers up on presenting promising data from studies
U.S. STOCKS ON THE MOVE-Energy firms, ImmunoGen, CIRCOR
Day One Biopharma rises on mid-stage trial data from brain tumor treatment